Chen Huang

ORCID: 0000-0002-2407-9716 · 8 papers in corpus
other 2026
Scientific reports ·doi:10.1038/s41598-026-51553-4

Ovarian cancer poses a significant clinical challenge due to its asymptomatic onset and poor prognosis, highlighting the critical need for effective early detection strategies. This study developed a framework that integrates serum proteomi…

other 2026
Translational andrology and urology ·doi:10.21037/tau-2026-0467

BACKGROUND: Ureteral reimplantation (UR) is the standard treatment for distal ureteral stricture, yet postoperative anastomotic restenosis impairs outcomes, with conventional imaging unable to quantify urinary tract obstruction and dysfunct…

observational 2023
Zhonghua fu chan ke za zhi ·doi:10.3760/cma.j.cn112141-20221222-00768

Objective: To investigate the familial heritability of endometriosis and to compare the clinical characteristics of patients with or without a family history of endometriosis. Methods: From January 2020 to June 2022, 850 patients with endom…

review 2022
Biomedicines ·doi:10.3390/biomedicines10081910

As a multifaceted adipokine, chemerin has been found to perform functions vital for immunity, adiposity, and metabolism through its three known receptors (chemokine-like receptor 1, CMKLR1; G-protein-coupled receptor 1, GPR1; C-C motif chem…

rct 2022
Frontiers in pharmacology ·doi:10.3389/fphar.2022.935117

Objectives: This study examined the dose-effect relationship of chitosan and danshen combined injections on the long-term prevention of fallopian tube re-obstructions, with increased pregnancy rates in infertile women. Methods: High-perform…

2022
·doi:10.2139/ssrn.4049631
lab-animal 2022
Frontiers in pharmacology ·doi:10.3389/fphar.2022.985618

Endometriosis is a common gynecological disease, characterized by the presence of endometrial-like lesions outside the uterus. This debilitating disease causes chronic pelvic pain and infertility with limited therapeutics. Chemerin is a sec…

rct 2019
Drug delivery and translational research ·doi:10.1007/s13346-018-00611-0

To prospectively study the efficacy of different anti-adhesion agents for the prevention of tubal obstruction after recanalization, this trial was approved by our hospital ethics committee. Four hundred patients with fallopian tube obstruct…